Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims dataMeiqi He, Laura K Ferris, Nico Gabriel, et al.
Diabetes Research and Clinical Practice|March 29, 2022
Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetesJing Luo, Nico Gabriel, Mary Korytkowski, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Limited utility of price transparency data for drugsYuvraj Pathak, Elvira Makk Frid, Nico Gabriel, et al.
Molecular Endocrinology (Baltimore, Md.)|March 18, 2006
Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptorMasayuki Shimada, Inmaculada Hernandez-Gonzalez, Ignacio Gonzalez-Robayna, et al.
JAMA|March 26, 2019
Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018Inmaculada Hernandez, Chester B Good, William H Shrank, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Cheaper is not always better: Drug shortages in the United States and a value-based solution to alleviate themInmaculada Hernandez, Sean D Sullivan, Ryan N Hansen, et al.
JAMA Network Open|December 14, 2019
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar CompetitionAlvaro San-Juan-Rodriguez, Walid F Gellad, Chester B Good, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2021
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 CountriesInmaculada Hernandez, Mina Tadrous, Jared W Magnani, et al.
JAMA Health Forum|February 28, 2025
Overpayment for Generic Drugs Under Medicare Part DInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA Network Open|September 26, 2022
Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018Olivier J Wouters, Lucas A Berenbrok, Meiqi He, et al.
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims dataMeiqi He, Laura K Ferris, Nico Gabriel, et al.
Diabetes Research and Clinical Practice|March 29, 2022
Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetesJing Luo, Nico Gabriel, Mary Korytkowski, et al.
Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Limited utility of price transparency data for drugsYuvraj Pathak, Elvira Makk Frid, Nico Gabriel, et al.
Molecular Endocrinology (Baltimore, Md.)|March 18, 2006
Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptorMasayuki Shimada, Inmaculada Hernandez-Gonzalez, Ignacio Gonzalez-Robayna, et al.
JAMA|March 26, 2019
Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018Inmaculada Hernandez, Chester B Good, William H Shrank, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Cheaper is not always better: Drug shortages in the United States and a value-based solution to alleviate themInmaculada Hernandez, Sean D Sullivan, Ryan N Hansen, et al.
JAMA Network Open|December 14, 2019
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar CompetitionAlvaro San-Juan-Rodriguez, Walid F Gellad, Chester B Good, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2021
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 CountriesInmaculada Hernandez, Mina Tadrous, Jared W Magnani, et al.
JAMA Health Forum|February 28, 2025
Overpayment for Generic Drugs Under Medicare Part DInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA Network Open|September 26, 2022
Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018Olivier J Wouters, Lucas A Berenbrok, Meiqi He, et al.
Pageof 19